Neuland Laboratories Limited

NSEI:NEULANDLAB Stock Report

Market Cap: ₹96.7b

Neuland Laboratories Management

Management criteria checks 2/4

Neuland Laboratories' CEO is Davuluri Rao, appointed in Aug 2013, has a tenure of 10.75 years. total yearly compensation is ₹57.50M, comprised of 34.5% salary and 65.5% bonuses, including company stock and options. directly owns 3.3% of the company’s shares, worth ₹3.19B. The average tenure of the management team and the board of directors is 3.7 years and 9.5 years respectively.

Key information

Davuluri Rao

Chief executive officer

₹57.5m

Total compensation

CEO salary percentage34.5%
CEO tenure10.8yrs
CEO ownership3.3%
Management average tenure3.7yrs
Board average tenure9.5yrs

Recent management updates

Recent updates

There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump

Apr 19
There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump

We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease

Apr 15
We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease

Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%

Feb 17
Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%

Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates

Feb 12
Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates

Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

Jan 05
Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount

Nov 12
The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount

Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today

Oct 27
Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today

Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

Aug 24
Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically

Aug 05
Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically

Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Jul 05
Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Jun 21
Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

May 14
Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?

May 12
Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?

Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly

Aug 30
Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly

I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut

Feb 23
I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut

The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically

Feb 03
The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically

Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet

Mar 15
Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet

Can You Imagine How Elated Neuland Laboratories' (NSE:NEULANDLAB) Shareholders Feel About Its 391% Share Price Gain?

Feb 28
Can You Imagine How Elated Neuland Laboratories' (NSE:NEULANDLAB) Shareholders Feel About Its 391% Share Price Gain?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Neuland Laboratories Limited (NSE:NEULANDLAB)

Feb 12
Don't Ignore The Fact That This Insider Just Sold Some Shares In Neuland Laboratories Limited (NSE:NEULANDLAB)

Neuland Laboratories Limited (NSE:NEULANDLAB) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 04
Neuland Laboratories Limited (NSE:NEULANDLAB) Just Reported And Analysts Have Been Lifting Their Price Targets

Neuland Laboratories Limited's (NSE:NEULANDLAB) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Feb 03
Neuland Laboratories Limited's (NSE:NEULANDLAB) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Read This Before Selling Neuland Laboratories Limited (NSE:NEULANDLAB) Shares

Jan 18
Read This Before Selling Neuland Laboratories Limited (NSE:NEULANDLAB) Shares

If You Like EPS Growth Then Check Out Neuland Laboratories (NSE:NEULANDLAB) Before It's Too Late

Jan 01
If You Like EPS Growth Then Check Out Neuland Laboratories (NSE:NEULANDLAB) Before It's Too Late

Is Neuland Laboratories Limited (NSE:NEULANDLAB) Popular Amongst Insiders?

Dec 14
Is Neuland Laboratories Limited (NSE:NEULANDLAB) Popular Amongst Insiders?

Did Business Growth Power Neuland Laboratories' (NSE:NEULANDLAB) Share Price Gain of 117%?

Nov 26
Did Business Growth Power Neuland Laboratories' (NSE:NEULANDLAB) Share Price Gain of 117%?

CEO Compensation Analysis

How has Davuluri Rao's remuneration changed compared to Neuland Laboratories's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

₹3b

Sep 30 2023n/an/a

₹3b

Jun 30 2023n/an/a

₹2b

Mar 31 2023₹58m₹20m

₹2b

Dec 31 2022n/an/a

₹1b

Sep 30 2022n/an/a

₹831m

Jun 30 2022n/an/a

₹651m

Mar 31 2022₹30m₹15m

₹638m

Dec 31 2021n/an/a

₹593m

Sep 30 2021n/an/a

₹731m

Jun 30 2021n/an/a

₹742m

Mar 31 2021₹34m₹11m

₹806m

Dec 31 2020n/an/a

₹540m

Sep 30 2020n/an/a

₹384m

Jun 30 2020n/an/a

₹257m

Mar 31 2020₹22m₹10m

₹162m

Dec 31 2019n/an/a

₹321m

Sep 30 2019n/an/a

₹257m

Jun 30 2019n/an/a

₹216m

Mar 31 2019₹13m₹10m

₹164m

Mar 31 2018₹5m₹3m

₹121m

Compensation vs Market: Davuluri's total compensation ($USD689.71K) is above average for companies of similar size in the Indian market ($USD381.28K).

Compensation vs Earnings: Davuluri's compensation has increased by more than 20% in the past year.

CEO

Davuluri Rao (48 yo)

10.8yrs

Tenure

₹57,500,000

Compensation

Mr. Davuluri Sucheth Rao has been the Chief Executive Officer of Neuland Laboratories Limited since August 1, 2013, where Mr. Rao also served as its Chief Operating Officer. At Neuland, Sucheth has been re...

Leadership Team

NamePositionTenureCompensationOwnership
Davuluri Rama Rao
Executive Chairman & Chief Promoter40.3yrs₹60.00m26.37%
₹ 25.5b
Davuluri Rao
Vice Chairman & CEO10.8yrs₹57.50m3.3%
₹ 3.2b
Davuluri Rao
Vice Chairman & MD14.9yrs₹57.50m2.24%
₹ 2.2b
Abhijit Majumdar
Chief Financial Officer1.5yrsno datano data
Sharadsrikar Kotturi
Chief Scientific Officerless than a yearno datano data
Sarada Bhamidipati
Company Secretary & Compliance Officer12.3yrsno datano data
Y. Sudheer
Head of Marketingno datano datano data
Shashank Mahashabde
President of Business Development & Contract Manufacturingno datano datano data
Ashutosh Sinha
Chief Quality Officerless than a yearno datano data
Bharadwaj Gollapudi
Deputy General Managerno datano datano data

3.7yrs

Average Tenure

54yo

Average Age

Experienced Management: NEULANDLAB's management team is considered experienced (3.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Davuluri Rama Rao
Executive Chairman & Chief Promoter40.3yrs₹60.00m26.37%
₹ 25.5b
Davuluri Rao
Vice Chairman & CEO20.8yrs₹57.50m3.3%
₹ 3.2b
Davuluri Rao
Vice Chairman & MD14.9yrs₹57.50m2.24%
₹ 2.2b
Prasad Menon
Independent Director1.5yrs₹1.74mno data
Homi Khusrokhan
Non-Executive Independent Director5.3yrs₹2.19mno data
Bharati Rao
Non-Executive & Independent Director10yrs₹2.21mno data
Sugata Sircar
Independent Directorless than a yearno datano data
Christopher Cimarusti
Non-Executive Director14.6yrs₹1.75mno data
Nirmala Murthy
Non-Executive Independent Director9yrs₹2.11mno data
Pallavi Bakhru
Independent Directorless than a yearno datano data

9.5yrs

Average Tenure

77yo

Average Age

Experienced Board: NEULANDLAB's board of directors are considered experienced (9.5 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.